Fundraising Fox

株式会社digzyme

Tokyo, JP · Founded 2019 · 11 employees on LinkedIn · 3 known investors

Digzyme develops novel enzymes and bioprocesses to order, providing enzyme libraries, sample supply, IP licensing, and support for scale-up, commercialization, and regulatory approvals. It serves industrial clients seeking custom enzyme solutions in the biotech sector.

Also known as digzyme · Digzyme Inc. · 株式会社digzyme

Founders & leadership

株式会社digzyme was founded in 2019 by Naoki Watarai, Yuya Nakamura, and Takuji Yamada.

NW
Naoki WataraiCo-founder & CEO
YN
Yuya NakamuraCo-founder & CTO
TY
Takuji YamadaCo-founder & CSO
TM
Takuo MiyauchiCSMO
KK
Kazuki KawabeCFO

Investors · 3

Company profile

researched Aug 2026

株式会社digzyme is a Tokyo-based enzyme development platform company. Its stated premise is that industrially useful enzymes have historically been discovered largely by chance, making enzyme development slow and costly because identifying the gene encoding an enzyme suited to a given purpose requires extensive trial and error. digzyme's approach is to interpret the large volumes of accumulated life-science research data published worldwide in order to design, in silico, enzyme genes suited to industrial applications.

The company packages this into three service lines: enzyme-oriented new-business development consulting supported by bioinformatics analysis; enzyme search, enzyme design and construction of application-specific enzyme libraries (digzyme Designed Library™); and research and development services for the manufacture and sale of enzymes and compounds, including designing production processes at an appropriate scale and volume. Services can be engaged individually or in combination. The company also publishes technical content through a TechBlog covering topics such as in silico designed enzymes for control of food and food-residue molecules, and physics-simulation-based enzyme design as a complement to AI methods.

Business model

digzyme positions itself as an enzyme development platform provider, offering consulting, bioinformatics-based enzyme discovery and design, enzyme library construction, and R&D services for enzyme and compound manufacturing, either as standalone engagements or combined.

Latest developments

In 2026 digzyme joined a NEDO bio-manufacturing program project on fiber-to-fiber resource circulation as a subcontractor (May), was covered in the June 2026 issue of Monthly Fine Chemical, was selected for the Exhibition Support Program of the Asia-Pacific Agri-Food Innovation Summit in Singapore (July), and announced a CFO speaking appearance at the Bio AI Summit 2026 in September.

Full profile — market position, technology, go-to-market, geography

Market position

Rather than relying on chance discovery of enzymes, the company designs candidate enzyme genes computationally from published life-science data and maintains pre-designed enzyme libraries to shorten the path from customer requirement to manufacturing.

Technology

Proprietary analysis technology that reads and interprets heterogeneous, large-scale life-science research data to efficiently design enzyme genes for industrial use, with the designed enzymes accumulated into reusable libraries (digzyme Designed Library™) so that enzymes matching a customer need can be moved quickly into production. Company technical content also describes the use of physics-based simulation alongside AI in enzyme design.

Go-to-market

Direct inquiry and consulting engagements via the company website, supplemented by conference exhibitions and speaking slots (ifia JAPAN 2026, 食品開発展 2025, Bio AI Summit 2026, Asia-Pacific Agri-Food Innovation Summit), trade-press coverage, and participation in publicly funded programs such as NEDO projects.

Companies pursuing enzyme-based new business creation or growth of existing businesses in manufacturing, including food and food-residue processing and textile/fiber resource circulation applications.

Geography

Headquartered in Tokyo, Japan, with outbound activity in Asia-Pacific including selection for an exhibition support program tied to a Singapore summit.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Competitors · 2

by search overlap

Companies competing with 株式会社digzyme for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline · 4

launches, deals, and filings
Sep 2026
CFO Kawabe to speak at Bio AI Summit 2026

Announced on 2026-08-24 that CFO Kazuki Kawabe would present at the Bio AI Summit 2026 on September 17.

source ↗

Jul 2026
Selected for Exhibition Support Program of Singapore's Asia-Pacific Agri-Food Innovation Summit

digzyme announced it was selected for the Exhibition Support Program of the ASIA-PACIFIC AGRI-FOOD INNOVATION SUMMIT held in Singapore.

source ↗

Jun 2026
Featured in Monthly Fine Chemical magazine (June 2026 issue)

source ↗

May 2026
Participation as subcontractor in NEDO bio-manufacturing project on fiber-to-fiber resource circulation

digzyme joined NEDO's bio-manufacturing revolution promotion program project on research and demonstration toward building fiber-to-fiber resource circulation, as a subcontracted party.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does 株式会社digzyme do?
Japanese enzyme development platform company using bioinformatics to design industrial enzymes and bioprocesses.
Who founded 株式会社digzyme?
株式会社digzyme was founded by Naoki Watarai, Yuya Nakamura, Takuji Yamada in 2019.
Who are 株式会社digzyme's investors?
株式会社digzyme's investors include DG Daiwa Ventures, MIRAI SOUZOU, Mobile Internet Capital, Inc..
Where is 株式会社digzyme headquartered?
株式会社digzyme is headquartered in Tokyo, JP.